Recognizing the significant disease burden, the Chinese government has prioritized stroke as a key focus in the Healthy China 2030 initiative. Concrete implementation steps and milestones have been set to systematically address this pressing issue.
Boehringer Ingelheim is a leading acute stroke treatment company. Our Total Stroke Solution (TSS) covers the entire patient journey, from prevention and education to detection and treatment. With our deep understanding of unmet needs throughout the patient journey, we are uniquely positioned to address the challenges faced by stroke patients.
One pain point Boehringer observed is that low health literacy leaves many people in China unaware of how to prevent, detect, and respond to stroke incidents. To address this, Boehringer took proactive steps. We supported the Chinese national government to initiate the Healthy China: Stroke Family Care Project in 2023. Our online platform published nearly 100 original quality authoritative short videos and 185 images/articles, reaching over one billion content exposure and 17,646 direct views in the campaign year. This groundbreaking grant project marks the first time such an initiative has been undertaken by Healthy China 2030, and Boehringer is proud to be the first and only company providing support to enhance the general public’s health literacy in 2023.